We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+18.44%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$845M
AUM Growth
+$279M
Cap. Flow
+$203M
Cap. Flow %
23.97%
Top 10 Hldgs %
63.74%
Holding
124
New
76
Increased
6
Reduced
15
Closed
19

Top Buys

Rank Stock Value
1
BUD icon
AB InBev
BUD
+$16.9M
2
SN icon
SharkNinja
SN
+$12.6M
3
AHR icon
American Healthcare REIT
AHR
+$9.21M
4
KSPI icon
Kaspi.kz JSC
KSPI
+$8.9M
5
ODD icon
ODDITY Tech
ODD
+$8.85M

Top Sells

Rank Stock Value
1
PCG icon
PG&E
PCG
+$4.69M
2
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$4.11M
3
GPCR icon
Structure Therapeutics
GPCR
+$4.1M
4
ARGX icon
argenx
ARGX
+$3.8M
5
LVS icon
Las Vegas Sands
LVS
+$3.69M

Sector Composition

Rank Sector Weight
1 Healthcare 15.07%
2 Industrials 5.62%
3 Consumer Staples 3.94%
4 Technology 3.82%
5 Consumer Discretionary 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALIT icon
101
Alight
ALIT
$394M
$98.5K 0.01%
+500
New +$90.5K
ANTX icon
102
AN2 Therapeutics
ANTX
$213M
– –
-33,997
Closed -$697K
ARGX icon
103
argenx
ARGX
$54.2B
– –
-10,000
Closed -$3.8M
AURA icon
104
Aura Biosciences
AURA
$796M
– –
-198,415
Closed -$1.76M
BLUE
105
DELISTED
bluebird bio
BLUE
– –
-25,000
Closed -$690K
ETNB
106
DELISTED
89bio
ETNB
– –
-140,000
Closed -$1.56M
FLNC icon
107
Fluence Energy
FLNC
$2.34B
– –
-100,000
Closed -$2.38M
HCI icon
108
HCI Group
HCI
$2.36B
– –
-19,790
Closed -$1.73M
KPTI icon
109
Karyopharm Therapeutics
KPTI
$44.4M
– –
-8,829
Closed -$34.9K
KVYO icon
110
Klaviyo
KVYO
$5.09B
– –
-68,974
Closed -$1.92M
LVS icon
111
Las Vegas Sands
LVS
$29.4B
– –
-75,000
Closed -$3.69M
MYGN icon
112
Myriad Genetics
MYGN
$311M
– –
-50,000
Closed -$957K
PCG icon
113
PG&E
PCG
$37.5B
– –
-260,000
Closed -$4.69M
PCT icon
114
PureCycle Technologies
PCT
$1.46B
– –
-11,754
Closed -$47.6K
PR
115
Permian Resources
PR
$17.8B
– –
-175,900
Closed -$2.39M
SEAT icon
116
Vivid Seats
SEAT
$82.6M
– –
-1,500
Closed -$190K
STTK icon
117
Shattuck Labs
STTK
$682M
– –
-100,000
Closed -$713K
SWTX
118
DELISTED
SpringWorks Therapeutics
SWTX
– –
-73,949
Closed -$2.7M
WVE icon
119
Wave Life Sciences
WVE
$1.2B
– –
-103,300
Closed -$522K
AMAM
120
DELISTED
Ambrx Biopharma Inc
AMAM
– –
-207,500
Closed -$2.95M
1 2 3 4
5

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, Monashee Investment Management held 124 positions worth $845M, up 49% from $567M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Monashee Investment Management deployed $203M of net new capital in Q1 2024, opening 76 new positions and adding to 6 existing holdings. Its largest new stake was AB InBev: 270,100 shares worth $16.4M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 9.1% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $4.11M trimmed.

  • Monashee Investment Management's largest Q1 2024 buy was AB InBev: 270,100 shares worth $16.4M.
  • Monashee Investment Management added most to Vaxcyte in Q1 2024, an estimated $4.33M increase.
  • Monashee Investment Management's biggest Q1 2024 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $4.11M.
  • Monashee Investment Management fully exited PG&E in Q1 2024, selling an estimated $4.69M.
  • Monashee Investment Management's ten largest holdings make up 64% of its $845M portfolio in Q1 2024.
  • Monashee Investment Management opened 76 new positions and closed 19 in Q1 2024.
  • Monashee Investment Management's portfolio value rose 49% quarter-over-quarter to $845M.

Based on Monashee Investment Management's 13F filing for Q1 2024, filed 14 May 2024.